-
Mashup Score: 103Erik K Singhi, MD on Twitter - 7 month(s) ago
Lung cancer STAGING takes the CENTER STAGE at #WCLC23 9th edition updates: T: No changes N: N2 N2a (station N2) & N2b (Multistation N2) M: M1c M1c1 (Multi extrathoracic mets,organ) & M1c2 (Multi extrathoracic mets, multiple organs) @OncoAlert @IASLC #lcsm
Source: The Fellow On CallCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 124Rami Manochakian, MD on Twitter - 7 month(s) ago@OncoAlert Hot off the press, presented @IASLC #WCLC23, results of #FLAURA2 trial showed statistically significant & clinically meaningful #PFS benefit of #Osimertinib + Chemo vs #Osimertinib alone, as 1st line Treatment in Patients with #EGFRm Advanced #NSCLC. mPFS: By investigator; 25.5 vs 16.7 months HR: 0.62 By BICR; 29.4 vs 19.9 months HR: 0.62 OS data immature Grade ≥3 AEs (Osi + chemo vs Osi) 64% vs 27%Source: The Fellow On CallCategories: Hem/Oncs, Latest HeadlinesTweet
-
You may recall that in Episode 033 of The Fellow on Call, we discussed the use of osimertinib, an tyrosine kinase inhibitor specific for EGFR, as the standard of care for patients with metastatic non-small cell lung cancer (https://www.thefellowoncall.com/tfocpodcast/jt7mmp342rn85wy-stczg), based on the results of the FLAURA study. At the recent WCLC, results of the FLAURA2 study were shared, highlighting improvements in PFS when osimertinib was combined with chemotherapy. This is most definitely exciting, but what remains to be seen is if we can better identify who would benefit from this the most. As the study shows, there was more toxicity associated with the addition of chemotherapy!
-
-
Mashup Score: 0Our Episodes — The Fellow On Call - 8 month(s) ago
Listen to our episodes, read our episode shownotes, and review our references all on your favorite podcast-streaming platforms:Spotify Apple PodcastsGoogle PodcastsLinks to all of our episodes, the shownotes, and references can also be found below.Thanks so much for tuning in; We are are so glad you are here. …
Source: The Fellow On CallCategories: Latest Headlines, Partners & KOLsTweet
-
Mashup Score: 0Rotation Guide: Introduction to Hematopathology — The Fellow On Call - 8 month(s) ago
Introduction to Hematopathology
Source: The Fellow On CallCategories: Latest Headlines, Partners & KOLsTweet
-
Mashup Score: 0Episode 064: Breast Cancer Series, Pt. 9-Triple Negative, Early Stage Breast Cancer — The Fellow On Call - 10 month(s) ago
Episode 064: Breast Cancer Series, Pt. 9-Triple Negative, Early Stage Breast Cancer This week, we round out our discussion on the early stage breast cancer, turning our attention to the triple negative subtype. Once again, there are a lot of trials and data, but be sure to check out the show notes
Source: The Fellow On CallCategories: Latest Headlines, Partners & KOLsTweet
-
Mashup Score: 0The Fellow On Call - 10 month(s) ago
An educational podcast about all things hematology and oncology! In each episode, we will provide bite-sized, simplified approaches to common questions in a way that is perfect for anyone interested in hematology and oncology, from medical students to medicine residents, hematology/oncology fellows
Source: The Fellow On CallCategories: Latest Headlines, Partners & KOLsTweet
-
Mashup Score: 0The Fellow On Call - 10 month(s) ago
An educational podcast about all things hematology and oncology! In each episode, we will provide bite-sized, simplified approaches to common questions in a way that is perfect for anyone interested in hematology and oncology, from medical students to medicine residents, hematology/oncology fellows
Source: The Fellow On CallCategories: Latest Headlines, Partners & KOLsTweet
-
Mashup Score: 0Our Episodes — The Fellow On Call - 10 month(s) ago
Listen to our episodes, read our episode shownotes, and review our references all on your favorite podcast-streaming platforms:Spotify Apple PodcastsGoogle PodcastsLinks to all of our episodes, the shownotes, and references can also be found below.Thanks so much for tuning in; We are are so glad you are here. …
Source: The Fellow On CallCategories: Latest Headlines, Partners & KOLsTweet
-
Mashup Score: 0Rotation Guides — The Fellow On Call - 10 month(s) ago
Are you starting a new rotation and just don’t know where to begin? Well, we have the answer for you. Check out our episodes, broken down by rotation-type. We will do our best to update this regularly!
Source: The Fellow On CallCategories: Latest Headlines, Partners & KOLsTweet
-
Mashup Score: 0Episode 063: Breast Cancer Series, Pt. 8-HER2+, Early Stage Breast Cancer — The Fellow On Call - 10 month(s) ago
Episode 063: Breast Cancer Series, Pt. 8-HER2+, Early Stage Breast Cancer We continue on our journey through early stage breast cancer, this time turning our attention to HER2+ disease. There is a lot of data in this episode, as you will both hear and see. To make this easier, we highlight key take
Source: The Fellow On CallCategories: Latest Headlines, Partners & KOLsTweet
In case you missed it, the IASLC 2023 World Conference on Lung Cancer (WCLC) just happened a few weeks back, held in beautiful Singapore. Amongst the topics of discussion were changes to the TNM staging for lung cancer. Although these have not been formally announced, definitely worth noting and keeping an eye out for!